Anti-topoisomerase 1 antibody level changes after B сell depletion therapy in systemic sclerosis

The aim of our study was to assess the relationship between the changes of antinuclear autoantibodies (ANA) and autoantibodies to topoisomerase 1 (anti-Topo 1) in systemic sclerosis (SSc) patients on rituximab (RTX) therapy.Materials and methods. The prospective study included 88 patients (73 women)...

Descripció completa

Dades bibliogràfiques

Autors principals:	L. P. Ananyeva, L. A. Garzanova, O. A. Koneva, M. N. Starovoytova, O. V. Desinova, O. B. Ovsyannikova, R. U. Shayakhmetova, M. V. Cherkasova, A. P. Aleksankin, E. L. Nasonov
Format:	Artigo
Idioma:	Russo
Publicat:	IMA PRESS LLC 2022-03-01
Col·lecció:	Научно-практическая ревматология
Matèries:	systemic sclerosis antinuclear antibody anti-topoisomerase 1 antibody interstitial lung disease rituximab
Accés en línia:	https://rsp.mediar-press.net/rsp/article/view/3117
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!